{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T11:11:18Z","timestamp":1760094678475,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.biopha.2003.06.002","type":"journal-article","created":{"date-parts":[[2003,9,22]],"date-time":"2003-09-22T15:25:23Z","timestamp":1064244323000},"page":"422-427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Risk factors for lipodystrophy in the CISAI cohort"],"prefix":"10.1016","volume":"57","author":[{"given":"Paolo","family":"Bonfanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Gulisano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lia","family":"Timillero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Valsecchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Carradori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Pusterla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paolo","family":"Fortuna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastiano","family":"Miccolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Magnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gabbuti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Parazzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canio","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivano","family":"Faggion","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simona","family":"Landonio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziana","family":"Quirino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GianMarco","family":"Vigevani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2003.06.002_BIB1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jama.279.6.450","article-title":"Improved survival among HIV-infected individuals following initiation of antiretroviral therapy","volume":"279","author":"Hogg","year":"1998","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.biopha.2003.06.002_BIB2","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"New Engl J Med"},{"key":"10.1016\/j.biopha.2003.06.002_BIB3","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(97)11443-X","article-title":"Buffalo hump in men with HIV-1 infection","volume":"351","author":"Lo","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2003.06.002_BIB4","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00042560-199811010-00015","article-title":"Body shape changes in HIV-infected patients","volume":"19","author":"Lo","year":"1998","journal-title":"J Acquired Immune Defic Syndromes"},{"key":"10.1016\/j.biopha.2003.06.002_BIB5","first-page":"107","article-title":"Changes in body habitus and serum lipid abnormalities in HIV-positive women on HAART","volume":"21","author":"Dong","year":"1999","journal-title":"J Acquired Immune Defic Syndromes"},{"key":"10.1016\/j.biopha.2003.06.002_BIB6","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00002030-199903110-00004","article-title":"Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy","volume":"13","author":"Gervasoni","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2003.06.002_BIB7","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal-fat accumulation associated with use of indinavir","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2003.06.002_BIB8","doi-asserted-by":"crossref","first-page":"F25","DOI":"10.1097\/00002030-200002180-00001","article-title":"A syndrome of lipoatrophy, lactic acidemia, and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome","volume":"14","author":"Carr","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2003.06.002_BIB9","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/ajcn\/69.6.1162","article-title":"Fat distribution in HIV-infected patients reporting truncal enlargement quantified by whole-body magnetic resonance imaging","volume":"69","author":"Engelson","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.biopha.2003.06.002_BIB10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/00042560-199903010-00003","article-title":"Studies of body composition and fat distribution in HIV-infected and control subjects","volume":"20","author":"Kotler","year":"1999","journal-title":"J Acquired Immune Defic Syndromes"},{"key":"10.1016\/j.biopha.2003.06.002_BIB11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00002030-199904160-00020","article-title":"Lipodystrophy in patients na\u00efve to HIV protease inhibitors","volume":"13","author":"Madge","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2003.06.002_BIB12","doi-asserted-by":"crossref","first-page":"F51","DOI":"10.1097\/00002030-199807000-00003","article-title":"A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIB protease inhibitors","volume":"12","author":"Carr","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2003.06.002_BIB13","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1016\/S0140-6736(98)08468-2","article-title":"Diagnosis, prediction, and natural course of HIV-1 protease inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study","volume":"353","author":"Carr","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2003.06.002_BIB14","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1097\/00002030-199909100-00009","article-title":"A syndrome of peripheral fat wasting in patients receiving long-term nucleoside analogue therapy","volume":"13","author":"Saint Marc","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2003.06.002_BIB15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1-infected patients treated with protease inhibitors: a prospective cohort study","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2003.06.002_BIB16","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1097\/00002030-199907300-00004","article-title":"Epidemiological and clinical aspects of the metabolic complications of HIV infection: the fat redistribution syndrome","volume":"13","author":"Wanke","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2003.06.002_BIB17","first-page":"123","article-title":"Lipodystrophy and hyperglycemia produced by protease inhibitors","volume":"17","author":"Reus","year":"2000","journal-title":"Ann Med Interne"},{"key":"10.1016\/j.biopha.2003.06.002_BIB18","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/00042560-200003010-00004","article-title":"Incidence of adverse reactions in HIV patients treated with protease inhibitors: a cohort study","volume":"23","author":"Bonfanti","year":"2000","journal-title":"J Acquired Immune Defic Syndromes"},{"key":"10.1016\/j.biopha.2003.06.002_BIB19","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00001432-200202000-00003","article-title":"Methods of assessing body shape and composition in HIV-associated lipodystrophy","volume":"15","author":"Schwenk","year":"2002","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.biopha.2003.06.002_BIB20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.biopha.2003.06.002_BIB21","doi-asserted-by":"crossref","first-page":"2621","DOI":"10.1001\/archinte.162.22.2621","article-title":"Incidence of adipose tissue alterations in first-line antiretroviral therapy","volume":"162","author":"Galli","year":"2002","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.biopha.2003.06.002_BIB22","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00126334-200108150-00004","article-title":"Lipodystrophic syndromes and hyperlipidemia in cohort of HIV-1 infected patients receiving triple combination antiretroviral therapy with a protease inhibitor","volume":"27","author":"Rokotoambinina","year":"2001","journal-title":"J Acquired Immune Defic Syndromes"},{"key":"10.1016\/j.biopha.2003.06.002_BIB23","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/00126334-200209010-00007","article-title":"Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs","volume":"31","author":"Bernasconi","year":"2002","journal-title":"J Acquired Immune Defic Syndromes"},{"key":"10.1016\/j.biopha.2003.06.002_BIB24","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/00042560-200208010-00010","article-title":"Antiretroviral treatment patterns and incident HIV-associated morphologic and lipid abnormalities in a population-based cohort","volume":"30","author":"Heath","year":"2002","journal-title":"J Acquired Immune Defic Syndromes"},{"key":"10.1016\/j.biopha.2003.06.002_BIB25","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","article-title":"Clinical assessment of HIV-associated lipodystrophy in an ambulatory population","volume":"15","author":"Lichtenstein","year":"2001","journal-title":"AIDS"},{"issue":"13","key":"10.1016\/j.biopha.2003.06.002_BIB26","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/archinte.160.13.2050","article-title":"Effect of protease inhibitors on hyperglycemia, and lipodystropy: a 5-year cohort study","volume":"160","author":"Tsidras","year":"2000","journal-title":"Arch Intern Med"},{"issue":"6","key":"10.1016\/j.biopha.2003.06.002_BIB27","doi-asserted-by":"crossref","first-page":"F37","DOI":"10.1097\/00002030-199806000-00001","article-title":"Indinavir-associated lipodystrophy","volume":"12","author":"Viraben","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2003.06.002_BIB28","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1258\/095646202760029813","article-title":"Self-reported signs of lipodystrophy by persons living with HIV infection","volume":"13","author":"Dreezen","year":"2002","journal-title":"Int J Std AIDS"},{"key":"10.1016\/j.biopha.2003.06.002_BIB29","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00126334-200010010-00007","article-title":"Fat redistribution in indinavir-treated with HIV infection: a review of postmarketing cases","volume":"25","author":"Benson","year":"2000","journal-title":"J Acquired Immune Defic Syndromes"},{"key":"10.1016\/j.biopha.2003.06.002_BIB30","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0140-6736(97)11518-5","article-title":"Visceral abdominal fat accumulation associated with use of indinavir","volume":"351","author":"Miller","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2003.06.002_BIB31","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1086\/317541","article-title":"Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy","volume":"32","author":"Hadigan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.biopha.2003.06.002_BIB32","first-page":"1932","article-title":"Fasting hyperinsulinemia and changes in regional body composition in human immunodeficiency virus-infected woman","volume":"84","author":"Hadigan","year":"1999","journal-title":"J Clin Endocrin Metab"},{"issue":"10","key":"10.1016\/j.biopha.2003.06.002_BIB33","first-page":"589","article-title":"Interaction among sex, HIV infection and fat redistribution","volume":"10","author":"Lopes","year":"2000","journal-title":"AIDS Read"},{"key":"10.1016\/j.biopha.2003.06.002_BIB34","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1097\/00002030-200007070-00002","article-title":"Contribution of nucleoside analogue reverse trascriptase inhibitors to subcutaneous fat wasting in patients with HIV infection","volume":"14","author":"Mallal","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2003.06.002_BIB35","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00002030-200001070-00005","article-title":"Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO Study","volume":"14","author":"Saint Marc","year":"2000","journal-title":"AIDS"},{"article-title":"Risk factor associated with types of metabolic and morphological alterations according to the Marrakesh classification","year":"2000","author":"Galli","key":"10.1016\/j.biopha.2003.06.002_BIB36"},{"key":"10.1016\/j.biopha.2003.06.002_BIB37","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1310\/BRE5-448N-WUPU-JWVL","article-title":"Lipodystrophy in 685\u00a0HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response","volume":"2","author":"Boufassa","year":"2001","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.biopha.2003.06.002_BIB38","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/S0140-6736(00)04056-3","article-title":"Risk of lipodystrophy in HIV-1 infected patients treated with protease inhibitors: a prospective cohort study","volume":"357","author":"Martinez","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2003.06.002_BIB39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1177\/135965350100600102","article-title":"Antiretroviral therapy and the lipodystrophy syndrome","volume":"6","author":"Mina","year":"2001","journal-title":"Antiviral Ther"},{"key":"10.1016\/j.biopha.2003.06.002_BIB40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1046\/j.1468-1293.2001.00071.x","article-title":"HIV-associated lipodystrophy","volume":"2","author":"Mallon","year":"2001","journal-title":"HIV Med"},{"key":"10.1016\/j.biopha.2003.06.002_BIB41","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/00002030-200105040-00005","article-title":"Prometheus study group. Increased risk of lipodystrophy when nucleoside analogue reverse transcriptase inhibitors are included with protease inhibitors in the treatment of HIV-1 infection","volume":"15","author":"Van der Valk","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2003.06.002_BIB42","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1046\/j.1464-2662.2001.00100.x","article-title":"Risk factors for the HIV-associated lipodystrophy syndrome in a closed cohort of patients after 3\u00a0years of antiretroviral treatment","volume":"3","author":"Mauss","year":"2002","journal-title":"HIV Med"},{"key":"10.1016\/j.biopha.2003.06.002_BIB43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00002030-200101260-00013","article-title":"Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV\/AIDS treatment database","volume":"15","author":"Heath","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/j.biopha.2003.06.002_BIB44","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/00126334-200107010-00004","article-title":"Stavudine versus zidovudine and the development of lipodystrophy","volume":"27","author":"Bogner","year":"2001","journal-title":"J Acquired Immune Defic Syndromes"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332203001367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332203001367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:29:50Z","timestamp":1760092190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332203001367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S0753332203001367"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2003.06.002","relation":{},"ISSN":["0753-3322"],"issn-type":[{"type":"print","value":"0753-3322"}],"subject":[],"published":{"date-parts":[[2003,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for lipodystrophy in the CISAI cohort","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2003.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2003 \u00c9ditions scientifiques et m\u00e9dicales Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}